Lasofoxifene Tartrate CAS 190791-29-8 Chiral Ịdị Ọcha ≥99.0% Ịdị ọcha

Lasofoxifene Tartrate CAS 190791-29-8 Chiral Dị Ọcha ≥99.0% Ịdị Ọcha ≥98.0% (HPLC) API Ịdị Ọcha Dị Elu

Nkọwa dị mkpirikpi:

Aha Chemical: Lasofoxifene Tartrate

OZI: 190791-29-8

Ọdịdị: White ka Gbanyụọ-Ọcha ntụ ntụ

Ịdị ọcha nke Chiral: ≥99.0%Ịdị ọcha: ≥98.0% (HPLC)

Na ọgwụgwọ nke Postmenopausal Osteoporosis

API Ogo dị elu, mmepụta azụmahịa

Inquiry: alvin@ruifuchem.com

Zitere anyị email

Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Onye nrụpụta nwere ịdị ọcha dị elu yana ịdị mma kwụsie ike
Aha Chemical: Lasofoxifene Tartrate
OZI: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) na ọgwụgwọ nke Postmenopausal Osteoporosis

Njirimara kemịkalụ:

Aha Chemical	Lasofoxifene Tartrate
Ụdị okwu	(5R,6S) -5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2- (1-pyrrolidinyl) ethoxy] phenyl] -2-naphthalenol Tartrate Oporia
Nọmba CAS	190791-29-8
Nọmba CAT	RF-API20
Ọnọdụ Ahịa	Na Akụrụngwa, Mpụta Ihe ruru narị narị kilograms
Usoro ihe omimi	C28H31NO2.ClH
Ibu molekụla	450.019
Ụdị	Ruifu Chemical

Nkọwapụta:

Ihe	Nkọwapụta
Ọdịdị	Ọcha ka Gbanyụọ-Ọcha ntụ ntụ
Mmiri (KF)	≤0.50%
Ọla dị arọ	≤20ppm
Chiral ịdị ọcha	≥99.0%
Ụzọ ịdị ọcha / nyocha	≥98.0% (HPLC)
Ọnwụ na ihicha	≤0.50%
Ihe fọdụrụ na mgbanye	≤0.50%
Nlele ọkọlọtọ	Ndị China Pharmacopoeia (CP);Standardkpụrụ ụlọ ọrụ
Ojiji	Ngwakọta ọgwụ na-arụ ọrụ (API);Osteoporosis postmenopausal

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, kaadiboodu drum, 25kg / Drum, ma ọ bụ dị ka ndị ahịa chọrọ.

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ọkụ, mmiri mmiri na ụmụ ahụhụ.

Uru:

Ajụjụ:

Ngwa:

Shanghai Ruifu Chemical Co., Ltd. bụ onye na-emepụta ihe na onye na-ebubata Lasofoxifene Tartrate (CAS: 190791-29-8) nwere àgwà dị elu.
Lasofoxifene Tartrate bụ ọgbọ nke atọ, na-abụghị steroidal selective estrogen receptor modulator (SERM).Ọ na-ahọrọ ejikọta na ERalpha mmadụ nwere uru IC50 nke 1.5 nM ma na-egbochi ọkpụkpụ ọkpụkpụ na oke ovariectomized.Na nyocha ụlọ ọgwụ nke osteoporosis postmenopausal, 0.5 mg / ụbọchị lasofoxifene jikọtara ya na mbelata ihe ize ndụ nke mgbaji ndị na-abụghị vertebral na vertebral, ER-positive cancer cancer, ọrịa obi obi, na ọrịa strok mana ihe ize ndụ dị ukwuu nke ihe omume thromboembolic venous.E gosikwara Lasofoxifene ka ọ na-eme ihe dị ka agonist na-agbanwe agbanwe na CB2 cannabinoid onye na-anabata ya, na-egosi na ọ nwere ike ịmeghachi ya dị ka ọgwụgwọ maka ihe ngosi ebe CB2 bụ ihe mgbaru ọsọ.